Ann: Mayne Pharma completes E4/DRSP transaction and Appendix 3B, page-8

Eventually we all show our true colours.
Mine is the fact The CEO has been given
Carte Blanche in managing Mayne far too long
His backing by Powerful Board members
Chairman and large shareholder is not a good
thing.
Unfortunately due to his tra
ck record I have No
confidence in his ability to handle large
transactions during negotiation stage.
I really believe he thinks he has best deal
and fails.
Better off appointing firm to do this for you.
$5m , $10m $20m. Fee Who cares ????
They May have received equity in Mithra.
It doesn’t matter what just A B
etter Deal !
All round for Mayne. Mithra was a one man band 15 yes ago.
Scott has that time with Faulding Mayne
He is just not up to it . Although rewarded
as though he is.
i just am fearful Mayne future in his hands.
He is becoming like Disallowed salesman.
His wording Very Slick Indeed.